Not applicableStudy completedNCT06149221What this trial is testingPenetration-enhanced Direct DBD Non-thermal Plasma for Hair LossWho this might be right forAndrogenetic Alopecia Dr. Peter C. Friedman 19
Testing effectiveness (Phase 2)Study completedNCT03594227What this trial is testingATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia TotalisWho this might be right forAlopecia Aclaris Therapeutics, Inc. 87
Early research (Phase 1)Looking for participantsNCT07554222What this trial is testingStudy to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose AdministrationWho this might be right forHealthyActive Non-segmental VitiligoSevere Alopecia Areata Innovent Biologics (Suzhou) Co. Ltd. 160
Early research (Phase 1)WithdrawnNCT06045624What this trial is testingA First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy SubjectsWho this might be right forAlopecia Areata Ornovi, Inc.
Testing effectiveness (Phase 2)Study completedNCT06393452What this trial is testingSafety, Pharmacokinetics and Efficacy of PP405 in Adults With AGAWho this might be right forAndrogenetic Alopecia Pelage Pharmaceuticals, Inc. 78
Large-scale testing (Phase 3)UnknownNCT01655108What this trial is testingEfficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female PatientsWho this might be right forFemale Pattern Alopecia Brasilia University Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT05496426What this trial is testingKL130008 in Adults With Severe Alopecia AreataWho this might be right forAlopecia Areata Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 114
Not applicableEnded earlyNCT05761158What this trial is testingStudy of the Characteristics of Pruritus in Patients With Frontal Fibrosing Alopecia or Lichen Planus PilarisWho this might be right forAlopeciaLichen Planus University Hospital, Brest 21
Not applicableStudy completedNCT05759338What this trial is testingRevian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial AlopeciaWho this might be right forCentral Centrifugal Cicatricial Alopecia Wake Forest University Health Sciences 24
Large-scale testing (Phase 3)Study completedNCT05135468What this trial is testingClinical Study Patients With Androgenetic Alopecia (AGA)Who this might be right forAGA Cutia Therapeutics(Wuxi)Co.,Ltd 270
Post-approval studies (Phase 4)Study completedNCT00176943What this trial is testingCharacteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%Who this might be right forAlopecia Areata Hordinsky, Maria K., MD 20
Not applicableStudy completedNCT07615608What this trial is testingTHERAVEX® REGENERA Tissue Care Plus for Hair Regeneration and Follicular Microenvironment ModulationWho this might be right forAndrogenetic AlopeciaAlopeciaHair Loss+2 more Biointelligent Technology Systems SL 20
Testing effectiveness (Phase 2)Study completedNCT07076706What this trial is testingClinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic AlopeciaWho this might be right forMale Pattern of Hair Loss, Androgenic AlopeciaAndrogenetic Alopecia (AGA) Beijing Dayspring Pharmaceutical Technology Co., Ltd 110
Testing effectiveness (Phase 2)Study completedNCT00965640What this trial is testingTreatment of Male Pattern Baldness With Botulinum ToxinWho this might be right forMale Pattern Baldness The Crown Institute
Testing effectiveness (Phase 2)Looking for participantsNCT05398809What this trial is testingEvaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia AreataWho this might be right forAutoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced)Alopecia Areata National Institute of Allergy and Infectious Diseases (NIAID) 70
Testing effectiveness (Phase 2)Looking for participantsNCT07487948What this trial is testingSafety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen PlanopilarisWho this might be right forCentral Centrifugal Cicatricial AlopeciaLichen Planopilaris Icahn School of Medicine at Mount Sinai 30
Post-approval studies (Phase 4)UnknownNCT06043349What this trial is testingEffectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic AlopeciaWho this might be right forAndrogenetic Alopecia Universitas Indonesia 36
Very early researchEnded earlyNCT06932393What this trial is testingExosomes for Hairloss TreatmentWho this might be right forHair Loss Guangzhou Bio-gene Technology Co., Ltd 16
Not applicableNot Yet RecruitingNCT06326359What this trial is testingAutologous Stromal Vascular Fraction in Treatment of Male Androgenic AlopeciaWho this might be right forAndrogenic Alopecia Sohag University 40
Not applicableStudy completedNCT03331003What this trial is testing"iRestore" Light Therapy ApparatusWho this might be right forAlopecia National Taiwan University Hospital 100